User28823
do not go gentle into that good night
- Joined
- Aug 7, 2022
- Posts
- 38,593
- Reputation
- 70,635
VDPHL01 (Veradermics)
www.veradermics.com
brb buying 100 shares
- Basically oral minoxidil 2.0 without cardiac risk
- Same active drug (minoxidil), but in an extended-release formulation designed specifically for hair loss rather than blood pressure.
- Goal: smoother blood levels, less cardiovascular stress, similar or better hair growth than standard oral minoxidil.
- Phase 2/3 male trial just hit all primary endpoints with statistically significant hair growth and good safety data. One more pivotal Phase 3 readout is expected in H2 2026.
- Potential launch: late 2027–2028 if remaining studies and FDA review go well.
Dermatology and Aesthetics Solutions | Veradermics
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company.
brb buying 100 shares